JP2025501762A5 - - Google Patents
Info
- Publication number
- JP2025501762A5 JP2025501762A5 JP2024538278A JP2024538278A JP2025501762A5 JP 2025501762 A5 JP2025501762 A5 JP 2025501762A5 JP 2024538278 A JP2024538278 A JP 2024538278A JP 2024538278 A JP2024538278 A JP 2024538278A JP 2025501762 A5 JP2025501762 A5 JP 2025501762A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163292903P | 2021-12-22 | 2021-12-22 | |
| US63/292,903 | 2021-12-22 | ||
| US202263327228P | 2022-04-04 | 2022-04-04 | |
| US63/327,228 | 2022-04-04 | ||
| US202263403459P | 2022-09-02 | 2022-09-02 | |
| US63/403,459 | 2022-09-02 | ||
| PCT/US2022/053591 WO2023122140A1 (en) | 2021-12-22 | 2022-12-21 | Parp1 inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025501762A JP2025501762A (ja) | 2025-01-23 |
| JP2025501762A5 true JP2025501762A5 (https=) | 2026-01-06 |
| JPWO2023122140A5 JPWO2023122140A5 (https=) | 2026-01-06 |
Family
ID=85156997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538278A Pending JP2025501762A (ja) | 2021-12-22 | 2022-12-21 | Ｐａｒｐ１阻害剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20250163022A1 (https=) |
| EP (1) | EP4452963A1 (https=) |
| JP (1) | JP2025501762A (https=) |
| KR (1) | KR20240136978A (https=) |
| AU (1) | AU2022420969A1 (https=) |
| CA (1) | CA3241875A1 (https=) |
| CL (1) | CL2024001874A1 (https=) |
| CO (1) | CO2024009571A2 (https=) |
| CR (1) | CR20240296A (https=) |
| IL (1) | IL313727A (https=) |
| MX (1) | MX2024007673A (https=) |
| PE (1) | PE20242004A1 (https=) |
| TW (1) | TW202332438A (https=) |
| WO (1) | WO2023122140A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240208923A1 (en) | 2021-03-10 | 2024-06-27 | Jnana Therapeutics Inc. | Small molecule inhibitors of mammalian slc6a19 function |
| IL315586A (en) * | 2022-03-11 | 2024-11-01 | Impact Therapeutics Shanghai Inc | Substituted tricyclic compounds as parp inhibitors and the use thereof |
| KR20240161147A (ko) | 2022-03-14 | 2024-11-12 | 슬랩 파마슈티컬스 엘엘씨 | 다중 사이클릭 화합물 |
| EP4545531A1 (en) * | 2022-06-27 | 2025-04-30 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Tricyclic compounds and uses thereof |
| CN115232129B (zh) * | 2022-08-18 | 2023-12-01 | 上海闻耐医药科技有限公司 | 一种parp1选择性抑制剂及其制备方法和用途 |
| JP2025535834A (ja) * | 2022-11-02 | 2025-10-28 | スアンズ バイオファーマシューティカル カンパニー，リミテッド | 多環式ポリ（ａｄｐリボース）ポリメラーゼ選択的阻害剤 |
| JP2025538192A (ja) * | 2022-11-10 | 2025-11-26 | 上海海和薬物研究開発股▲ふん▼有限公司 | 縮合三環式ｐａｒｐ１阻害剤、その調製方法、および使用 |
| WO2024227026A1 (en) * | 2023-04-28 | 2024-10-31 | Synnovation Therapeutics, Inc. | Heterocyclic compounds as parp1 inhibitors |
| CN119462669A (zh) * | 2023-08-11 | 2025-02-18 | 上海海和药物研究开发股份有限公司 | 稠合三环类化合物、其药物组合物和用途 |
| WO2025067417A1 (zh) * | 2023-09-28 | 2025-04-03 | 成都赜灵生物医药科技有限公司 | 并内酰胺环类化合物及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2459561A1 (en) * | 2009-07-30 | 2012-06-06 | Takeda Pharmaceutical Company Limited | Poly (adp-ribose) polymerase (parp) inhibitors |
| CA2937012A1 (en) * | 2013-10-23 | 2015-04-30 | Sumitomo Dainippon Pharma Co., Ltd. | Fused pyrazole derivative |
| PH12017502228B1 (en) * | 2015-06-09 | 2022-08-03 | Onconic Therapeutics Inc | Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same |
| MX2022000711A (es) * | 2019-07-19 | 2022-02-23 | Astrazeneca Ab | Inhibidores de parp1. |
-
2022
- 2022-12-21 JP JP2024538278A patent/JP2025501762A/ja active Pending
- 2022-12-21 WO PCT/US2022/053591 patent/WO2023122140A1/en not_active Ceased
- 2022-12-21 EP EP22851230.7A patent/EP4452963A1/en active Pending
- 2022-12-21 PE PE2024001409A patent/PE20242004A1/es unknown
- 2022-12-21 AU AU2022420969A patent/AU2022420969A1/en active Pending
- 2022-12-21 IL IL313727A patent/IL313727A/en unknown
- 2022-12-21 CA CA3241875A patent/CA3241875A1/en active Pending
- 2022-12-21 KR KR1020247024155A patent/KR20240136978A/ko active Pending
- 2022-12-21 CR CR20240296A patent/CR20240296A/es unknown
- 2022-12-21 TW TW111149299A patent/TW202332438A/zh unknown
- 2022-12-21 MX MX2024007673A patent/MX2024007673A/es unknown
- 2022-12-21 US US18/728,407 patent/US20250163022A1/en active Pending
-
2024
- 2024-06-19 CL CL2024001874A patent/CL2024001874A1/es unknown
- 2024-07-19 CO CONC2024/0009571A patent/CO2024009571A2/es unknown